أحد الأهداف الرئيسية لـ Life4me + - منع حالات الإصابة الجديدة بفيروس نقص المناعة البشرية والأمراض المنقولة جنسياً الأخرى والتهاب الكبد الوبائي والسل.

يساعد التطبيق على تأسيس اتصال مجهول بين الأطباء والمصابين بفيروس نقص المناعة البشرية. انها تسمح لك بسهولة تنظيم جدول الدواء الخاص بك وإعداد تذكير خفية وشخصية.

إلى الوراء
٣٠ يوليو ٢٠١٨, ١٢:٠٣
1472

WHO has issued updated recommendations for the treatment of hepatitis C

WHO has issued updated recommendations for the treatment of hepatitis C - صورة 1

As the Coalition for Preparedness for Treatment (ITPCru) reported last week, in the end of July, on the eve of World Hepatitis Day, which was held this Saturday, the World Health Organization (WHO) prepared updated recommendations for the treatment of chronic hepatitis C.

According to the experts who analyzed the document, several provisions deserve special attention. First, the organization confirmed the adherence to the rule to treat all patients from 12 years of age and older with regimens including direct antiviral drugs (PDV).

Secondly, the WHO said that in the treatment of viral hepatitis C priority should be given to panthenotypic regimens.

Finally, the authors of the document do not recommend the use of direct-acting drugs for the treatment of the virus, when it comes to children under 12 years old. In this case, WHO recommends the use of interferon schemes.

As ITPCru adds, this part of the WHO will soon also be amended.

More details with updated recommendations can be found on the link.

مؤلف: ليليا تين

مشاركة على وسائل التواصل الاجتماعي